<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162980">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01719796</url>
  </required_header>
  <id_info>
    <org_study_id>KTAP</org_study_id>
    <nct_id>NCT01719796</nct_id>
  </id_info>
  <brief_title>Effect of TAP Block on Ventilatory Function Following Abdominal Surgery</brief_title>
  <acronym>KTAP</acronym>
  <official_title>Assessment of the Ventilatory Effects of Transverse Abdominal Plan Regional Analgesia Following Abdominal Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pierre and Marie Curie University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pierre and Marie Curie University</source>
  <oversight_info>
    <authority>France: Drug Safety National Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Abdominal surgery impairs ventilation. Postoperative pain accounts for this impairment.
      Regional analgesia is known to reduce pain, thus to limit ventilatory impairment. The
      investigators hypothesized bilateral continuous transverse abdominal plan block would reduce
      ventilatory impairment following abdominal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>vital capacity</measure>
    <time_frame>72h</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>maximum forced expiratory flow</measure>
    <time_frame>72h</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>72h</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain</measure>
    <time_frame>72h</time_frame>
    <safety_issue>No</safety_issue>
    <description>resting pain, assessed using VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diaphragmatic course</measure>
    <time_frame>72h</time_frame>
    <safety_issue>No</safety_issue>
    <description>using ultrasonography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Laparotomy</condition>
  <arm_group>
    <arm_group_label>Bilateral TAP catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasonography guided bilateral TAP catheter insertion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No TAP catheter</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Regional analgesia infusion</intervention_name>
    <arm_group_label>Bilateral TAP catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  laparotomy

        Exclusion Criteria:

          -  below 18, pregnancy, prisoners
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu RAUX, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Pierre et Marie Curie University, Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mathieu RAUX, MD, PhD</last_name>
    <phone>+33142177379</phone>
    <email>mathieu.raux@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philippe CUVILLON, MD, PhD</last_name>
    <phone>+33675303395</phone>
    <email>philippe.cuvillon@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nîmes</name>
      <address>
        <city>Nîmes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe CUVILLON, MD, PhD</last_name>
      <phone>+33675303395</phone>
      <email>philippe.cuvillon@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe CUVILLON, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Saint-Etienne</name>
      <address>
        <city>Saint-Etienne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge MOLLIEX, MD, PhD</last_name>
      <phone>+33477120922</phone>
      <email>serge.molliex@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>Serge MOLLIEX, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 30, 2012</lastchanged_date>
  <firstreceived_date>October 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pierre and Marie Curie University</investigator_affiliation>
    <investigator_full_name>Mathieu RAUX</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
